Wen-Cheng Wang Selected Research

AAP 10

1/2017

Improved Anticancer Photothermal Therapy Using the Bystander Effect Enhanced by Antiarrhythmic Peptide Conjugated Dopamine-Modified Reduced Graphene Oxide Nanocomposite.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Wen-Cheng Wang Research Topics

Disease

2	Atherosclerosis 09/2017 - 01/2016
2	Chronic Obstructive Pulmonary Disease (COPD) 01/2017 - 01/2016
1	Vascular Diseases (Vascular Disease) 09/2017
1	Acute Monocytic Leukemia (Acute Monoblastic Leukemia) 05/2017
1	Breast Neoplasms (Breast Cancer) 01/2017
1	Neoplasms (Cancer) 01/2017
1	Hypoxia (Hypoxemia) 09/2006

Drug/Important Bio-Agent (IBA)

2	graphene oxideIBA 05/2017 - 01/2017
2	Proteins (Proteins, Gene)FDA Link 01/2017 - 01/2017
1	rho-Associated KinasesIBA 09/2017
1	SootIBA 09/2017
1	Dopamine (Intropin)FDA LinkGeneric 01/2017
1	Benzo(a)pyreneIBA 01/2017
1	Connexin 43 (Connexin43)IBA 01/2017
1	AAP 10IBA 01/2017
1	Particulate MatterIBA 01/2017
1	Peptides (Polypeptides)IBA 01/2017
1	Polycyclic Aromatic Hydrocarbons (Polynuclear Aromatic Hydrocarbons)IBA 01/2017
1	polydopamineIBA 01/2017
1	CytokinesIBA 01/2017
1	oxidized low density lipoproteinIBA 01/2016
1	lead silicateIBA 09/2006

Therapy/Procedure

1	Photothermal Therapy 01/2017
1	Therapeutics 01/2017
1	Lasers (Laser) 09/2006